Literature DB >> 12970241

Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution.

Alain Bel1, Emmanuel Messas, Onnik Agbulut, Patrice Richard, Jane-Lyse Samuel, Patrick Bruneval, Albert A Hagège, Philippe Menasché.   

Abstract

BACKGROUND: As the benefits of extemporaneous transplantation (Tx) of fresh (unfractionated) autologous bone marrow (BM) have been primarily studied in the setting of acute myocardial infarction, we assessed whether this approach could be effective for regenerating chronically infarcted myocardium. METHODS AND
RESULTS: Myocardial infarction was created in 18 sheep by ligation of circumflex arterial branches. Three weeks later, BM was aspirated from the iliac crest, washed, labeled with the fluorescent dye Dil and reinjected (mean: 422 x 10(6) cells in 3 mL) in 10 sites across the infarcted area through the reopened thoracotomy (n=9). Nine controls received culture medium. Left ventricular (LV) function was assessed before and 2 months after Tx by two-dimensional echocardiography whereas transmural velocity gradients were measured using M-mode tissue Doppler imaging at the center of the infarcted/grafted area. Formalin-fixed hearts were processed for the detection of grafted cells and angiogenesis. LV ejection fraction deteriorated similarly in the Tx and control groups (from 42+/-5% to 30+/-4% and from 40+/-4% to 31+/-1%, respectively; P=0.86). Likewise, BM Tx failed to prevent LV dilatation and impairment of the global wall motion score. The decrease in regional systolic velocity gradients (s(-1)) featured a similar pattern (Tx group: from 0.77+/-0.11 to 0.31+/-0.07; control group: from 0.73+/-0.10 to 0.50+/-0.07; P=0.06). Histologically, there was neither BM tissue engraftment, except for a few scattered Dil-positive macrophages in the infarcted fibrotic areas nor transdifferentiation of BM cells into endothelial cells.
CONCLUSIONS: These data caution against the functional efficacy of extemporaneous Tx of fresh unfractionated BM into postinfarction scars.

Entities:  

Mesh:

Year:  2003        PMID: 12970241     DOI: 10.1161/01.cir.0000089040.11131.d4

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  30 in total

Review 1.  Delivery of gene and cellular therapies for heart disease.

Authors:  Justin A Mariani; David M Kaye
Journal:  J Cardiovasc Transl Res       Date:  2010-05-11       Impact factor: 4.132

Review 2.  Stem celltherapy for ischemic heart failure.

Authors:  Doreen Rosenstrauch; Gregor Poglajen; Nina Zidar; Igor D Gregoric
Journal:  Tex Heart Inst J       Date:  2005

Review 3.  Angiomyogenesis for myocardial repair.

Authors:  Husnain Kh Haider; Syed Ali Akbar; Muhammad Ashraf
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

Review 4.  Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions.

Authors:  Santosh K Sanganalmath; Roberto Bolli
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

5.  Benefit of stem cells and skeletal myoblast cells in dilated cardiomyopathies.

Authors:  Luiz César Guarita-Souza; Júlio César Francisco; Rossana Simeoni; Jose Rocha Faria-Neto; Katherine Athayde Teixeira de Carvalho
Journal:  World J Cardiol       Date:  2011-03-26

Review 6.  Preclinical Studies of Stem Cell Therapy for Heart Disease.

Authors:  Bryon A Tompkins; Wayne Balkan; Johannes Winkler; Mariann Gyöngyösi; Georg Goliasch; Francisco Fernández-Avilés; Joshua M Hare
Journal:  Circ Res       Date:  2018-03-30       Impact factor: 17.367

7.  Lipocalin-2-mediated upregulation of various antioxidants and growth factors protects bone marrow-derived mesenchymal stem cells against unfavorable microenvironments.

Authors:  Raheleh Halabian; Hossein Abdul Tehrani; Ali Jahanian-Najafabadi; Mehryar Habibi Roudkenar
Journal:  Cell Stress Chaperones       Date:  2013-04-26       Impact factor: 3.667

Review 8.  Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation.

Authors:  Husnain Kh Haider; Muhammad Ashraf
Journal:  J Mol Cell Cardiol       Date:  2008-05-10       Impact factor: 5.000

9.  Small intestinal submucosa gel as a potential scaffolding material for cardiac tissue engineering.

Authors:  Peter M Crapo; Yadong Wang
Journal:  Acta Biomater       Date:  2009-11-01       Impact factor: 8.947

Review 10.  Cell-based therapy for heart disease: a clinically oriented perspective.

Authors:  Philippe Menasche
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.